These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

2143 related items for PubMed ID: 16818529

  • 1. Pervasive developmental disorders in Montreal, Quebec, Canada: prevalence and links with immunizations.
    Fombonne E, Zakarian R, Bennett A, Meng L, McLean-Heywood D.
    Pediatrics; 2006 Jul; 118(1):e139-50. PubMed ID: 16818529
    [Abstract] [Full Text] [Related]

  • 2. Regression of language and non-language skills in pervasive developmental disorders.
    Meilleur AA, Fombonne E.
    J Intellect Disabil Res; 2009 Feb; 53(2):115-24. PubMed ID: 19054269
    [Abstract] [Full Text] [Related]

  • 3. Risk of immune thrombocytopenic purpura after measles-mumps-rubella immunization in children.
    France EK, Glanz J, Xu S, Hambidge S, Yamasaki K, Black SB, Marcy M, Mullooly JP, Jackson LA, Nordin J, Belongia EA, Hohman K, Chen RT, Davis R, Vaccine Safety Datalink Team.
    Pediatrics; 2008 Mar; 121(3):e687-92. PubMed ID: 18310189
    [Abstract] [Full Text] [Related]

  • 4. Autism spectrum disorders in young children: effect of changes in diagnostic practices.
    Nassar N, Dixon G, Bourke J, Bower C, Glasson E, de Klerk N, Leonard H.
    Int J Epidemiol; 2009 Oct; 38(5):1245-54. PubMed ID: 19737795
    [Abstract] [Full Text] [Related]

  • 5. A comparative evaluation of the effects of MMR immunization and mercury doses from thimerosal-containing childhood vaccines on the population prevalence of autism.
    Geier DA, Geier MR.
    Med Sci Monit; 2004 Mar; 10(3):PI33-9. PubMed ID: 14976450
    [Abstract] [Full Text] [Related]

  • 6. Evaluation of potentially common adverse events associated with the first and second doses of measles-mumps-rubella vaccine.
    LeBaron CW, Bi D, Sullivan BJ, Beck C, Gargiullo P.
    Pediatrics; 2006 Oct; 118(4):1422-30. PubMed ID: 17015532
    [Abstract] [Full Text] [Related]

  • 7. No evidence for a new variant of measles-mumps-rubella-induced autism.
    Fombonne E, Chakrabarti S.
    Pediatrics; 2001 Oct; 108(4):E58. PubMed ID: 11581466
    [Abstract] [Full Text] [Related]

  • 8. Risk factors for delayed immunization against measles, mumps, and rubella in Colorado two-year-olds.
    Miller LA, Hoffman RE, Barón AE, Marine WM, Melinkovich P.
    Pediatrics; 1994 Aug; 94(2 Pt 1):213-9. PubMed ID: 8036076
    [Abstract] [Full Text] [Related]

  • 9. A population-based study of measles, mumps, and rubella vaccination and autism.
    Madsen KM, Hviid A, Vestergaard M, Schendel D, Wohlfahrt J, Thorsen P, Olsen J, Melbye M.
    N Engl J Med; 2002 Nov 07; 347(19):1477-82. PubMed ID: 12421889
    [Abstract] [Full Text] [Related]

  • 10. Thimerosal exposure in infants and developmental disorders: a retrospective cohort study in the United kingdom does not support a causal association.
    Andrews N, Miller E, Grant A, Stowe J, Osborne V, Taylor B.
    Pediatrics; 2004 Sep 07; 114(3):584-91. PubMed ID: 15342825
    [Abstract] [Full Text] [Related]

  • 11. The rise in autism and the mercury myth.
    Scahill L, Bearss K.
    J Child Adolesc Psychiatr Nurs; 2009 Feb 07; 22(1):51-3. PubMed ID: 19200293
    [No Abstract] [Full Text] [Related]

  • 12. Atopic dermatitis is increased following vaccination for measles, mumps and rubella or measles infection.
    Olesen AB, Juul S, Thestrup-Pedersen K.
    Acta Derm Venereol; 2003 Feb 07; 83(6):445-50. PubMed ID: 14690341
    [Abstract] [Full Text] [Related]

  • 13. No effect of MMR withdrawal on the incidence of autism: a total population study.
    Honda H, Shimizu Y, Rutter M.
    J Child Psychol Psychiatry; 2005 Jun 07; 46(6):572-9. PubMed ID: 15877763
    [Abstract] [Full Text] [Related]

  • 14. [Evaluation of measles, mumps and rubella vaccine coverage in 3 year old children in twelve French counties. Time-trends and related factors].
    Rotily M, Guagliardo V, Fontaine D, Garros B, Mayer C, Arrighi J, Woronoff AS, Ledesert B, Lepec R, Chabaud F, Janvrin MP, Baudier F.
    Rev Epidemiol Sante Publique; 2001 Sep 07; 49(4):331-41. PubMed ID: 11567200
    [Abstract] [Full Text] [Related]

  • 15. Continuing increases in autism reported to California's developmental services system: mercury in retrograde.
    Schechter R, Grether JK.
    Arch Gen Psychiatry; 2008 Jan 07; 65(1):19-24. PubMed ID: 18180424
    [Abstract] [Full Text] [Related]

  • 16. Prevalence of IgG antibody against measles, mumps and rubella in bangladeshi children: a pilot study to evaluate the need for integrated vaccination strategy.
    Sultana R, Rahman MM, Hassan Z, Hassan MS.
    Scand J Immunol; 2006 Dec 07; 64(6):684-9. PubMed ID: 17083626
    [Abstract] [Full Text] [Related]

  • 17. An epidemiological study on Japanese autism concerning routine childhood immunization history.
    Takahashi H, Suzumura S, Shirakizawa F, Wada N, Tanaka-Taya K, Arai S, Okabe N, Ichikawa H, Sato T.
    Jpn J Infect Dis; 2003 Jun 07; 56(3):114-7. PubMed ID: 12944678
    [Abstract] [Full Text] [Related]

  • 18. The combined measles, mumps, and rubella vaccines and the total number of vaccines are not associated with development of autism spectrum disorder: the first case-control study in Asia.
    Uno Y, Uchiyama T, Kurosawa M, Aleksic B, Ozaki N.
    Vaccine; 2012 Jun 13; 30(28):4292-8. PubMed ID: 22521285
    [Abstract] [Full Text] [Related]

  • 19. Serosurvey of measles, mumps and rubella antibodies in Saudi children.
    Al-Mazrou YY, Khalil MK, Tischer A, Al-Jeffri MH, Al-Ghamdi YS, Bakhsh MM, Mishkas AA, Elgizouli SA.
    Saudi Med J; 2005 Oct 13; 26(10):1551-4. PubMed ID: 16228054
    [Abstract] [Full Text] [Related]

  • 20. Prevalence of pervasive developmental disorders among children at the English Montreal School Board.
    Lazoff T, Zhong L, Piperni T, Fombonne E.
    Can J Psychiatry; 2010 Nov 13; 55(11):715-20. PubMed ID: 21070699
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 108.